Etihad Airlines rolls out novel fuel efficient innovation ‘Greenliner’
By Nikita Chaurasia  Date: 2019-11-19

Etihad Airlines rolls out novel fuel efficient innovation ‘Greenliner’

These days, fuel efficiency and customer comfort has been on the priority for any automobile, ships, freight, and truck manufacturers. Walking on the same line is Abu Dhabi’ Etihad Airways pledging on saving the fuel and promoting environment friendliness.

The airways reportedly announced rolling out the world’s most fuel efficient airplane, Greenliner, with an intent to save the costs on fuel and stand as a more environment conscious choice for the global travelers. 

Greenline aircraft is Etihad’s Boing 787 Dreamline which is expected to take off its first route from Abu Dhabi to Brussels here in January. The CEO of Etihad, Tony Douglas, represents Greenliner as a flying laboratory for testing which could benefits the whole airline industry.  

Industry analysts claim that the fuel costs account to almost a quarter of the airline investments. On this the CEO addressed that the Boing was made on the grounds of saving over 20 per cent more fuel as compared to other aircrafts in the company’s fleet. The main aim of the Etihad airlines is to bring in focus its developments and achievements worldwide.

Speaking on the matter, Douglas quoted that the Greenliner not only leverages a provision of economical profit, but it also directly influences the carbon dioxide due to fuel burn. He further added that the company is laying high focus on the environment and the sustainability agenda. Douglas calls this launch as a first step towards the company’s contribution in green economy.

Despite the financial crisis faced by the company, Etihad has emerged to stand out amongst the most innovative airlines.

As per reliable records, the airlines in 2019 flew the world’s first passenger flight via the use of sustainable biofuel developed from a plant growing in saltwater. Additionally, the company has also become the first in the Middle East region to operate a flight san any single-use plastics on board to bring about the awareness of the negative impact of plastic pollution.
 

Source credit: https://www.latimes.com/business/story/2019-11-18/etihad-787-dreamliner-fuel-efficient

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fragomen acquires SimpleCitizen to reinforce its immigration services
Fragomen acquires SimpleCitizen to reinforce its immigration services
By Nikita Chaurasia

In a recent turn of events, Fragomen, Del Rey, Bernsen & Loewy, LLP, a leading corporate immigration law company has reportedly joined hands with SimpleCitizen Inc. to form Fragomen Technologies Inc., a new subsidiary which will provide a combina...

Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
By Nikita Chaurasia

Solar project development and asset management major, Nautilus Solar Energy LLC, has reportedly announced its acquisition of two solar portfolios in Rhode Island and Oregon amounting to a total of nearly 17 MW from leading solar energy developer, Pin...

Locate Bio obtains multiple late stage orthobiologics assets from RCSI
Locate Bio obtains multiple late stage orthobiologics assets from RCSI
By Nikita Chaurasia

Regenerative medicine major, Locate Bio, has reportedly announced its in-licensing of several late stage orthobiologics assets from the RCSI University of Medicine and Health Sciences. Sources state that the technologies created by the RCSI Tissue E...

Roche acquires Inflazome to gain control over inflammatory treatments
Roche acquires Inflazome to gain control over inflammatory treatments
By Nikita Chaurasia

In a recent turn of events, Swiss healthcare giant, F. Hoffmann-La Roche AG has reportedly acquired an Irish biotech firm Inflazome Ltd. for approximately USD 451 million (€380 million). As per the agreement, Roche will acquire complete rights ...

Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
By Nikita Chaurasia

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal presentation at ESMO (European Soci...